These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6352661)

  • 21. Randomized comparison of ceftazidime versus clindamycin-tobramycin in the treatment of obstetrical and gynecological infections.
    Blanco JD; Gibbs RS; Duff P; Castaneda YS; St Clair PJ
    Antimicrob Agents Chemother; 1983 Oct; 24(4):500-4. PubMed ID: 6360038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ceftazidime versus tobramycin/ticarcillin in treating hospital acquired pneumonia and bacteremia.
    Rapp RP; Young B; Foster TS; Tibbs PA; O'Neal W
    Pharmacotherapy; 1984; 4(4):211-5. PubMed ID: 6384945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
    Panda A; Ahuja R; Sastry SS
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ceftazidime in the treatment of febrile immunosuppressed children.
    Darbyshire PJ; Williamson PJ; Pedler SJ; Speller DC; Mott MG; Oakhill A
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():357-60. PubMed ID: 6352644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis.
    Permin H; Koch C; Høiby N; Christensen HO; Møller AF; Møller S
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():313-23. PubMed ID: 6352636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of infection with tobramycin-containing bone cement or systemic cefazolin in an animal model.
    Nijhof MW; Stallmann HP; Vogely HC; Fleer A; Schouls LM; Dhert WJ; Verbout AJ
    J Biomed Mater Res; 2000 Dec; 52(4):709-15. PubMed ID: 11033554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective comparison of cefoxitin and cefazolin in infections caused by aerobic bacteria.
    Gurwith M; Albritton W; Lank B; Harding G; Ronald A
    Antimicrob Agents Chemother; 1978 Feb; 13(2):255-60. PubMed ID: 348096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ceftazidime compared to tobramycin and ticarcillin in immunocompromised haematological patients.
    Reilly JT; Brada M; Bellingham AJ; Hart CA; Bennet C
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():89-92. PubMed ID: 6352660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial.
    Sharma N; Arora T; Jain V; Agarwal T; Jain R; Jain V; Yadav CP; Titiyal J; Satpathy G
    Cornea; 2016 Jan; 35(1):56-61. PubMed ID: 26509763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A clinical evaluation of the effect of cephacetrile on bacterial pneumonia. A comparative test with cefazolin by a double blind method (author's transl)].
    Matsumoto K; Noguchi Y; Uzuka Y; Kato Y; Saito A
    Jpn J Antibiot; 1976 Dec; 29(12):1070-92. PubMed ID: 796486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of the effects of ceftazidime compared with tobramycin plus cefamandole in the treatment of gall bladder empyema.
    Schoengut H; Jelinek R
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():219-22. PubMed ID: 6352622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative antimicrobial prophylaxis in cardiovascular surgery. A prospective randomized trial comparing two day cefuroxime prophylaxis with four day cefazolin prophylaxis.
    Geroulanos S; Oxelbark S; Turina M
    J Cardiovasc Surg (Torino); 1986; 27(3):300-6. PubMed ID: 3514630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Double-blind comparison of cefamandole and cefazolin in the therapy of respiratory tract infections (author's transl)].
    Jpn J Antibiot; 1980 Mar; 33(3):375-409. PubMed ID: 6995640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia.
    Schentag JJ; Vari AJ; Winslade NE; Swanson DJ; Smith IL; Simons GW; Vigano A
    Am J Med; 1985 Feb; 78(2A):34-41. PubMed ID: 3881947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Randomized prospective study of ceftazidime versus a cefotaxime-tobramycin combination in acute leukemia in therapeutic aplasia].
    Pellegrin JL; Marit G; Fourche J; Broustet A; Texier-Maugein J; Leng B; Reiffers J
    Presse Med; 1988 Oct; 17(37):1960-3. PubMed ID: 2973596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.
    Manley HJ; Bailie GR; Frye R; Hess LD; McGoldrick MD
    J Am Soc Nephrol; 2000 Jul; 11(7):1310-1316. PubMed ID: 10864588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
    Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB
    Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical evaluation of ceftazidime and the combined administration of cefotaxime and tobramycin in the treatment of urinary tract infections. Prospective and randomized studies].
    Wiecek A; Kokot F; Andrzejowska H; Grzeszczak W
    Pol Tyg Lek; 1986 Sep; 41(39):1242-6. PubMed ID: 3547357
    [No Abstract]   [Full Text] [Related]  

  • 39. Ceftazidime versus tobramycin plus ticarcillin in the treatment of soft-tissue infections.
    Solomkin JS; Cocchetto DM
    Clin Ther; 1986; 9(1):123-34. PubMed ID: 3545476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
    Gentry LO
    J Infect Dis; 1978 May; 137 Suppl():S144-S149. PubMed ID: 349093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.